Regeneron Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $2.62B | $2.00B | $614.6M | $432.0M |
| FY2021 | $7.08B | $6.53B | $551.9M | $601.7M |
| FY2022 | $5.01B | $4.42B | $590.1M | $725.0M |
| FY2023 | $4.59B | $3.88B | $718.6M | $885.0M |
| FY2024 | $4.42B | $3.66B | $755.9M | $982.8M |